China gave the green light to Eli Lilly & Co. s blockbuster drug tirzepatide for use in treating diabetes, a move that will intensify the drugmaker s rivalry with Novo Nordisk A/S over weight-loss drugs in the world s second-largest market.
China Clears Eli Lilly's Weight-Loss Drug, Only for Diabetes Now bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
China clears Lilly's weight-loss drug, only for diabetes now – Inside INdiana Business insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.
(Bloomberg) The increase in China’s consumer prices is expected to be short-lived, economists say, as the boost from a long holiday is overshadowed by signs of sluggish domestic demand. Most Read from BloombergOne of the Most Infamous Trades on Wall Street Is Roaring BackThese Are the Best Countries for Wealthy Expats‘Oppenheimer’ Wins Seven Oscars Including Best Picture, DirectorSlow US Inflation Retreat Is Set to Bolster Fed Patience on Rate CutsThe consumer price index’s 0.7% rise in Febru
Mark Mobius is urging caution about investing in China, warning that he has been prevented from accessing his money because of strict capital controls.